This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Elpiscience (Suzhou) Biopharma, Ltd. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Qinglin Du: Innovator in Biopharmaceuticals
Introduction
Qinglin Du is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on antibodies.
Latest Patents
Qinglin Du holds a patent for Anti-CD39 antibodies. This patent includes anti-CD39 antibodies or antigen-binding fragments, isolated polynucleotides encoding the same, pharmaceutical compositions comprising these antibodies, and their various uses.
Career Highlights
Qinglin Du is currently associated with Elpiscience (Suzhou) Biopharma, Ltd. His work at this company focuses on advancing therapeutic solutions in the biopharmaceutical sector.
Collaborations
He collaborates with notable colleagues such as Yangsheng Qiu and Meiling Sun, contributing to a dynamic research environment.
Conclusion
Qinglin Du's innovative work in the field of biopharmaceuticals, particularly with his patent on Anti-CD39 antibodies, showcases his commitment to advancing medical science.